{
    "medicine_id": "a5b16d24f1ea0a0220ad187a528be7f531fd15ae",
    "platform_id": "DB04934",
    "metadata": {
        "name": "Defitelio 80 mg 1mL Injection solution",
        "composition": "80 mg 1mL Rifalazil",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in atherosclerosis bacterial infection and peripheral vascular disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Rifalazil represents a new generation of ansamycins that contain a unique four ring structure Originally rifalazil was developed as a therapeutic agent to replace rifampin as part of a multiple drug regimen in the treatment of tuberculosis As a result of its superior antimicrobial activity and high intracellular levels rifalazil has potential to treat indications caused by the intracellular pathogen i Chlamydia trachomatis i which causes non gonococcal urethritis and cervicitis often leading to pelvic inflammatory disease Rifalazil also has potential to treat the related microorganism i Chlamydia pneumoniae i which may be involved in chronic inflammatory processes thought to be partly responsible for atherosclerosis Due to its favourable antimicrobial spectrum and other positive attributes rifalazil may also prove valuable in the treatment of gastric ulcer disease caused by i Helicobacter pylori i and antibiotic associated colitis the result of toxin production following the growth of i Clostridium difficile i in the colon The potential value of rifalazil in the treatment of these indications will be assessed in human clinical trials",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Rifalazil can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Rifalazil can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Rifalazil is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Rifalazil can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Rifalazil can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Rifalazil"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Rifalazil can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Rifalazil can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}